BFI Finance Indonesia Tbk vs Merck Tbk. — how do they compare? BFI Finance Indonesia Tbk trades at Rp785 (market cap 12.03T, 12.2M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: BFI Finance Indonesia Tbk is far larger — about 7.2× Merck Tbk.'s market cap, and BFI Finance Indonesia Tbk is more actively traded (12.2M versus 22.8K). Which is the better fit depends on your goals.
| BFIN | MERK | |
|---|---|---|
Market Cap | 12.03T | 1.68T |
Volume | 12.2M | 22.8K |
Lot | 122K | 228 |
Turnover | 9.55B | 82.9M |
Average Price | 782.93 | 3,636.14 |
Value | 9.55B | 82.9M |
Indicative Equilibrium Price | 785 | 3,520 |
Indicative Equilibrium Volume | 5.52K | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Read more on BFIN →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →